We are live on ! Find out more
PFC

Phocas Financial Corp Portfolio holdings

AUM $721M
1-Year Est. Return 63.77%
This Fund
S&P 500
This Quarter Est. Return
+4.8%
1 Year Est. Return
+63.77%
3 Year Est. Return
+170.38%
5 Year Est. Return
+211.85%
10 Year Est. Return
+808.48%
AUM
$749M
AUM Growth
+$723M
Cap. Flow
+$36.9M
Cap. Flow %
4.93%
Top 10 Hldgs %
18.33%
Holding
159
New
21
Increased
16
Reduced
96
Closed
5

Sector Composition

Rank Sector Weight
1 Financials 27.12%
2 Industrials 14.9%
3 Real Estate 11.72%
4 Healthcare 9.95%
5 Technology 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JACK icon
101
Jack in the Box
JACK
$312M
$2.86M 0.38%
68,612
-592
-0.9% -$27.3K
ACH
102
Accendra Health
ACH
$237M
$2.81M 0.38%
214,983
-1,981
-0.9% -$26.4K
MGY icon
103
Magnolia Oil & Gas
MGY
$6.09B
$2.79M 0.37%
119,349
+2,548
+2% +$66.2K
ELAN icon
104
Elanco Animal Health
ELAN
$13.2B
$2.76M 0.37%
227,624
-1,927
-0.8% -$25.2K
SCHX icon
105
Schwab US Large- Cap ETF
SCHX
$71.8B
$2.46M 0.33%
106,236
THRY icon
106
Thryv Holdings
THRY
$180M
$2.38M 0.32%
160,973
-1,470
-0.9% -$23.2K
PEB icon
107
Pebblebrook Hotel Trust
PEB
$2.15B
$2.34M 0.31%
172,587
-1,560
-0.9% -$20.6K
AAPL icon
108
Apple
AAPL
$4.54T
$2.34M 0.31%
9,325
-196
-2% -$46.2K
CDMO
109
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$2.27M 0.3%
183,432
-1,688
-0.9% -$19.3K
VCYT icon
110
Veracyte
VCYT
$3.7B
$2.06M 0.28%
52,109
-410
-0.8% -$15.5K
MDXG icon
111
MiMedx Group
MDXG
$602M
$2.02M 0.27%
+209,582
New +$1.63M
ACAD icon
112
Acadia Pharmaceuticals
ACAD
$4.43B
$1.98M 0.26%
107,811
+47,596
+79% +$768K
SEM
113
DELISTED
Select Medical
SEM
$1.88M 0.25%
+99,570
New +$1.92M
NVDA icon
114
NVIDIA
NVDA
$4.86T
$1.83M 0.24%
13,650
MSFT icon
115
Microsoft
MSFT
$3.45T
$1.78M 0.24%
4,215
GOOGL icon
116
Alphabet (Google) Class A
GOOGL
$4.36T
$1.66M 0.22%
8,784
ITCI
117
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.59M 0.21%
19,058
-175
-0.9% -$14.4K
MIRM icon
118
Mirum Pharmaceuticals
MIRM
$6.46B
$1.55M 0.21%
37,585
-304
-0.8% -$12.7K
AXSM icon
119
Axsome Therapeutics
AXSM
$11.2B
$1.49M 0.2%
17,546
-155
-0.9% -$14.3K
ETN icon
120
Eaton
ETN
$161B
$1.36M 0.18%
4,090
EQT icon
121
EQT Corp
EQT
$33.3B
$1.3M 0.17%
28,274
-3,691
-12% -$152K
BRK.B icon
122
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.09M 0.15%
2,412
SCHB icon
123
Schwab US Broad Market ETF
SCHB
$43.2B
$827K 0.11%
36,417
JNJ icon
124
Johnson & Johnson
JNJ
$618B
$823K 0.11%
5,689
DOV icon
125
Dover
DOV
$27.6B
$678K 0.09%
3,615

Similar funds

Phocas Financial Corp's Q4 2024 Portfolio in Review

As of Q4 2024, Phocas Financial Corp held 159 positions worth $749M, up 2,763% from $26.2M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Phocas Financial Corp deployed $36.9M of net new capital in Q4 2024, opening 21 new positions and adding to 16 existing holdings. Its largest new stake was White Mountains Insurance: 5,702 shares worth $11.1M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 7.4% a quarter earlier, followed by Industrials and Real Estate.

On the sell side, the largest reduction was Skywest, an estimated $4.41M trimmed.

  • Phocas Financial Corp's largest Q4 2024 buy was White Mountains Insurance: 5,702 shares worth $11.1M.
  • Phocas Financial Corp added most to Synovus in Q4 2024, an estimated $4.35M increase.
  • Phocas Financial Corp's biggest Q4 2024 reduction was Skywest, cutting an estimated $4.41M.
  • Phocas Financial Corp fully exited Tenet Healthcare in Q4 2024, selling an estimated $8.15K.
  • Phocas Financial Corp's ten largest holdings make up 18% of its $749M portfolio in Q4 2024.
  • Phocas Financial Corp opened 21 new positions and closed 5 in Q4 2024.
  • Phocas Financial Corp's portfolio value rose 2,763% quarter-over-quarter to $749M.

Based on Phocas Financial Corp's 13F filing for Q4 2024, filed 5 Feb 2025.